HC Wainwright Issues Positive Forecast for Personalis (NASDAQ:PSNL) Stock Price

Personalis (NASDAQ:PSNL) had its price target boosted by stock analysts at HC Wainwright from $8.50 to $10.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 30.55% from the stock’s current price.

A number of other equities analysts have also issued reports on PSNL. Needham & Company LLC increased their price target on Personalis from $7.00 to $10.00 and gave the company a “buy” rating in a research note on Wednesday. Wall Street Zen raised Personalis from a “sell” rating to a “hold” rating in a research note on Saturday, September 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of Personalis in a research note on Wednesday, October 8th. BTIG Research raised their price objective on Personalis from $6.00 to $11.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Lake Street Capital reissued a “buy” rating and set a $11.00 price objective on shares of Personalis in a research note on Wednesday. Six analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $9.33.

Personalis Price Performance

Shares of PSNL stock opened at $7.66 on Thursday. The business has a 50 day simple moving average of $7.24 and a 200 day simple moving average of $6.02. The firm has a market capitalization of $679.27 million, a price-to-earnings ratio of -8.70 and a beta of 1.92. Personalis has a 12-month low of $2.83 and a 12-month high of $10.95.

Personalis (NASDAQ:PSNL) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.04. The firm had revenue of $14.50 million during the quarter, compared to analyst estimates of $13.31 million. Personalis had a negative return on equity of 36.87% and a negative net margin of 106.92%. Personalis has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, equities analysts anticipate that Personalis will post -1.4 EPS for the current fiscal year.

Insider Activity

In other news, CEO Christopher M. Hall sold 29,612 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $8.99, for a total value of $266,211.88. Following the completion of the sale, the chief executive officer owned 148,486 shares in the company, valued at $1,334,889.14. This represents a 16.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.80% of the stock is owned by insiders.

Institutional Trading of Personalis

A number of hedge funds have recently modified their holdings of PSNL. China Universal Asset Management Co. Ltd. lifted its holdings in shares of Personalis by 18.2% in the first quarter. China Universal Asset Management Co. Ltd. now owns 17,704 shares of the company’s stock valued at $62,000 after purchasing an additional 2,724 shares in the last quarter. AIGH Capital Management LLC raised its holdings in shares of Personalis by 4.5% during the first quarter. AIGH Capital Management LLC now owns 3,968,948 shares of the company’s stock worth $13,931,000 after acquiring an additional 169,884 shares in the last quarter. ARK Investment Management LLC raised its holdings in shares of Personalis by 6.1% during the first quarter. ARK Investment Management LLC now owns 7,188,197 shares of the company’s stock worth $25,231,000 after acquiring an additional 412,762 shares in the last quarter. XTX Topco Ltd raised its holdings in shares of Personalis by 147.0% during the first quarter. XTX Topco Ltd now owns 82,666 shares of the company’s stock worth $290,000 after acquiring an additional 49,197 shares in the last quarter. Finally, Howland Capital Management LLC raised its holdings in shares of Personalis by 7.7% during the first quarter. Howland Capital Management LLC now owns 282,808 shares of the company’s stock worth $993,000 after acquiring an additional 20,200 shares in the last quarter. Hedge funds and other institutional investors own 61.91% of the company’s stock.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.